COMPANY

Enyx Therapeutics LLC

HQ: New York, NY source

Location: New York, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

Funding and NIH signals

NIH award NIH awarded $792K (STTR Phase II 5R42AA028465-03, continuation, notice Aug 13, 2026). NIH RePORTER 5R42AA028465-03 (Aug 13, 2026)
Evidence (1 event)
- Aug 13, 2026 · NIH RePORTER 5R42AA028465-03
  Organization: ENYX THERAPEUTICS, LLC; City/State: NEW YORK, NY; Project number: 5R42AA028465-03; Activity code: R42; Fiscal year: 2026; Award notice date: 2026-08-13; FY total cost (award amount): 791929; Administering IC: National Institute on Alcohol Abuse and Alcoholism; Project title: Gene Therapy to Treat Ethanol-induced Osteoporosis Associated with Aldehyde Dehydrogenase 2 Deficiency in Post-menopausal East Asian Women; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals